These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A role for collagen IV cross-links in conferring immune privilege to the Goodpasture autoantigen: structural basis for the crypticity of B cell epitopes. Vanacore RM; Ham AJ; Cartailler JP; Sundaramoorthy M; Todd P; Pedchenko V; Sado Y; Borza DB; Hudson BG J Biol Chem; 2008 Aug; 283(33):22737-48. PubMed ID: 18499662 [TBL] [Abstract][Full Text] [Related]
3. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. Pedchenko V; Bondar O; Fogo AB; Vanacore R; Voziyan P; Kitching AR; Wieslander J; Kashtan C; Borza DB; Neilson EG; Wilson CB; Hudson BG N Engl J Med; 2010 Jul; 363(4):343-54. PubMed ID: 20660402 [TBL] [Abstract][Full Text] [Related]
4. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells. Ooi JD; Holdsworth SR; Kitching AR J Autoimmun; 2008 Nov; 31(3):295-300. PubMed ID: 18502098 [TBL] [Abstract][Full Text] [Related]
5. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease. Cui Z; Zhao MH; Jia XY; Wang M; Hu SY; Wang SX; Yu F; Brown KL; Hudson BG; Pedchenko V J Autoimmun; 2016 Jun; 70():1-11. PubMed ID: 27117167 [TBL] [Abstract][Full Text] [Related]
10. Analysis of T cell responses to the autoantigen in Goodpasture's disease. Derry CJ; Ross CN; Lombardi G; Mason PD; Rees AJ; Lechler RI; Pusey CD Clin Exp Immunol; 1995 May; 100(2):262-8. PubMed ID: 7743665 [TBL] [Abstract][Full Text] [Related]
11. The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease. Cairns LS; Phelps RG; Bowie L; Hall AM; Saweirs WW; Rees AJ; Barker RN J Am Soc Nephrol; 2003 Nov; 14(11):2801-12. PubMed ID: 14569090 [TBL] [Abstract][Full Text] [Related]
12. The pathogenicity of T cell epitopes on human Goodpasture antigen and its critical amino acid motif. Hu SY; Gu QH; Wang J; Wang M; Jia XY; Cui Z; Zhao MH J Cell Mol Med; 2017 Sep; 21(9):2117-2128. PubMed ID: 28296059 [TBL] [Abstract][Full Text] [Related]
13. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition. Ryan JJ; Mason PJ; Pusey CD; Turner N Clin Exp Immunol; 1998 Jul; 113(1):17-27. PubMed ID: 9697978 [TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease. Borza DB; Hudson BG Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332 [TBL] [Abstract][Full Text] [Related]
15. Healthy individuals have Goodpasture autoantigen-reactive T cells. Zou J; Hannier S; Cairns LS; Barker RN; Rees AJ; Turner AN; Phelps RG J Am Soc Nephrol; 2008 Feb; 19(2):396-404. PubMed ID: 18216317 [TBL] [Abstract][Full Text] [Related]
16. Modeling of human anti-GBM antibody-alpha3(IV)NC1 interactions predicts antigenic cross-linking through contact of both heavy chains with repeating epitopes on alpha3(IV)NC1. Meyers KE; Christensen M; Madaio MP Am J Nephrol; 2009; 30(5):474-80. PubMed ID: 19786737 [TBL] [Abstract][Full Text] [Related]